-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Clinical rationale of sucroferric oxyhydroxide for controlling hyperphosphatemia in patients with chronic kidney disease
Stuart M Sprague, Morgan Marcuccilli & Viatcheslav Rakov
Drug Evaluation: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Overcoming the logistics of immune monitoring of cancer patients during clinical trials
Marc S Ernstoff
Editorial: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Inhibitors of JAK for the treatment of rheumatoid arthritis: rationale and clinical data
Charles J Malemud
Therapeutic Perspective: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Design of clinical trials for biomarker research in oncology
Sumithra J Mandrekar, Daniel J Sargent
Clinical Trail Outcomes: Clinical Investigation
-
Challenges in the clinical development of stem cell therapy
Natasa Levicar, Nagy A Habib
Editorial: Clinical Investigation
-
Challenges in the clinical development of stem cell therapy
Natasa Levicar, Nagy A Habib
Editorial: Clinical Investigation
-
Challenges in the clinical development of stem cell therapy
Natasa Levicar, Nagy A Habib
Editorial: Clinical Investigation
-
Challenges in the clinical development of stem cell therapy
Natasa Levicar, Nagy A Habib
Editorial: Clinical Investigation
-
Challenges in the clinical development of stem cell therapy
Natasa Levicar, Nagy A Habib
Editorial: Clinical Investigation
-
Challenges in the clinical development of stem cell therapy
Natasa Levicar, Nagy A Habib
Editorial: Clinical Investigation